Position in TSHA
as of Mar 31, 2026
· filed May 5, 2026
Position Value
$2,314,110
+$207,374 QoQ
Shares Held
517,698
+35.2% QoQ
Ownership
0.180%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2020
23 quarters on record
Voting authority
Sole 96.98666017639627.ToString("F0")%
Shared 0.ToString("F0")%
None 3.0133398236037228.ToString("F0")%
Common Shares in TSHA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026UBS Group AG holds $8,307,109,707 across 562 Biotechnology names. TSHA ranks #201 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ROIV |
Roivant Sciences Ltd.
|
22,619,472 | $626,559,372 | |
| 2 | PTGX |
Protagonist Therapeutics, Inc
|
5,177,796 | $545,739,697 | |
| 3 | ABVX |
Abivax S.A.
|
4,547,406 | $506,353,656 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
4,386,791 | $426,615,424 | |
| 5 | INSM |
INSMED Inc
|
1,737,481 | $284,112,890 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
630,618 | $281,596,158 | |
| 7 | APLS |
Apellis Pharmaceuticals, Inc.
|
6,206,681 | $249,694,775 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
299,979 | $231,775,770 |
All Filings in TSHA
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,314,110 | 517,698 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $2,106,736 | 383,043 | Shares | Defined | 2026-01-29 | |
| 2025-09-30 | $2,090,693 | 639,356 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $603,462 | 261,239 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $581,202 | 418,132 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $729,014 | 421,396 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $184,921 | 92,001 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $125,616 | 56,079 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $543,244 | 189,284 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $6,978 | 3,943 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $1,738 | 550 | Shares | Defined | 2023-11-09 | |
| 2023-06-30 | $5,227 | 7,909 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $2,832 | 3,550 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $456,144 | 201,834 | Shares | Defined | 2023-02-08 | |
| 2022-09-30 | $12,104 | 6,272 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $351,763 | 94,560 | Shares | Defined | 2022-08-10 | |
| 2022-03-31 | $443,229 | 67,980 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $594,568 | 51,036 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $621,591 | 33,383 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $112,360 | 5,300 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $735,083 | 36,211 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $948,778 | 35,749 | Shares | Defined | 2021-02-11 | |
| 2020-09-30 | $246,400 | 11,000 | Shares | Defined | 2020-11-12 | |
| No filing history on record for this holder in this stock. | ||||||